Literature DB >> 12700839

[The interruption of outpatient clinical care of HIV-infected patients].

Celeste S Rodrigues1, Mark D C Guimarães, Francisco A Acurcio, Cibele C Comini.   

Abstract

OBJECTIVE: To determine factors associated with the interruption of outpatient care of HIV-positive patients.
METHODS: Non-concurrent prospective study carried out in a public AIDS referral center in Belo Horizonte, Brazil. Medical records were reviewed in order to assess factors associated with the interruption of clinical care of HIV patients admitted between 1993 and 1995. Patients should have attended at least one follow-up visit within a period of 7 months. Statistical analysis was carried out using Chi-square and relative hazard (RH) with 95% confidence interval (CI) estimated by Cox Regression Model.
RESULTS: Cumulative incidence of interruption was 54% among 517 patients included in the study (mean follow-up=24.6 months; 26.5/100 person-years). Multivariate analysis indicated that those individuals who had fewer (<2) CD4+ T lymphocyte cell counts (RH=1.94; 95% CI=1.32-2.84) did not have viral load measured (RH=14.94; IC 95%=5.44-41.04), attended <7 medical follow-up visits (RH =2.80; IC 95%=1.89-4.14), did not change clinical category (RH =1.40; IC 95% =1.00-1.93) and did not undergo any anti-retroviral therapy (RH =1.43; IC 95% =1.06-1.93) had independently an increased risk of interrupting clinical care.
CONCLUSIONS: The rate of clinical interruption in this center is high. The results suggest that interruption may be a function of better clinical outcome, i.e. the service may give priority to those patients with more severe clinical condition, and interruption of clinical care may be a marker for future antiretroviral compliance.

Entities:  

Mesh:

Year:  2003        PMID: 12700839     DOI: 10.1590/s0034-89102003000200004

Source DB:  PubMed          Journal:  Rev Saude Publica        ISSN: 0034-8910            Impact factor:   2.106


  2 in total

1.  The Initial Months of Antiretroviral Therapy and Its Influence on AGEs, HMGB1, and sRAGE Levels in Asymptomatic HIV-Infected Individuals.

Authors:  Karen Ingrid Tasca; Juliana Trindade Caleffi; Camila Renata Correa; Mariana Gatto; Caio Cavassan de Camargo; Monica Bannwart Mendes; Marjorie de Assis Golim; Mara Biasin; Lenice do Rosário de Souza
Journal:  Mediators Inflamm       Date:  2016-11-30       Impact factor: 4.711

2.  Factors associated with mortality in HIV patients failing antiretroviral therapy, in Salvador, Brazil.

Authors:  Tatiana Haguihara; Márcio da Oliveira Silva; Monaliza Cardozo Rebouças; Eduardo Martins Netto; Carlos Brites
Journal:  Braz J Infect Dis       Date:  2019-07-10       Impact factor: 3.257

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.